WellCell Holdings Co., Limited (HKG:2477)
Hong Kong · Delayed Price · Currency is HKD 0.2140
+0.0040 (1.90%)
Sep 11, 2026, 10:14 AM HKT
WellCell Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 211.09 | 218.53 | 278.22 | 255.96 | 226.51 | 203.34 | |
Revenue Growth | -19.49% | -21.46% | 8.70% | 13.00% | 11.40% | 3.97% |
Cost of Revenue | 208.4 | 195.85 | 236.05 | 57.63 | 38.22 | 29.17 |
Gross Profit | 2.69 | 22.68 | 42.17 | 198.33 | 188.29 | 174.17 |
Selling, General & Admin | 4.71 | 4.71 | 4.82 | 0 | 20.19 | 46.43 |
Other Operating Expenses | 44.28 | 16.61 | 8.7 | 3.98 | 1.72 | 1.59 |
Operating Expenses | 67.35 | 33.81 | 20.99 | 6.52 | 28.3 | 50.47 |
Operating Income | -64.66 | -11.13 | 21.18 | 191.81 | 159.99 | 123.7 |
Interest Expense | -0.89 | -1.08 | -0.88 | -1.08 | -0.9 | -0.38 |
Interest & Investment Income | 0.15 | 0.2 | 1.92 | 0.21 | 0.09 | 0.05 |
Currency Exchange Gain (Loss) | -0.05 | -3.03 | 2.99 | -0.05 | -0.04 | -0.1 |
Other Non Operating Income (Expenses) | 0.09 | -0.18 | -5.89 | -13.95 | -8.31 | -6.51 |
EBT Excluding Unusual Items | -65.37 | -15.22 | 19.32 | 176.93 | 150.84 | 116.77 |
Merger & Restructuring Charges | - | - | - | -153.85 | -121.59 | -86.59 |
Gain (Loss) on Sale of Investments | 31.08 | 31.08 | 2.6 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.02 | -0.02 |
Pretax Income | -34.29 | 15.85 | 21.92 | 23.08 | 29.27 | 30.15 |
Income Tax Expense | 0.01 | 0.61 | 1.78 | 2.69 | 5.01 | 4.62 |
Earnings From Continuing Operations | -34.3 | 15.24 | 20.14 | 20.4 | 24.26 | 25.52 |
Minority Interest in Earnings | 0.3 | 0.1 | - | - | - | - |
Net Income | -34 | 15.34 | 20.14 | 20.4 | 24.26 | 25.52 |
Net Income to Common | -34 | 15.34 | 20.14 | 20.4 | 24.26 | 25.52 |
Net Income Growth | - | -23.85% | -1.26% | -15.92% | -4.96% | -13.94% |
Shares Outstanding (Basic) | 4,000 | 4,000 | 3,970 | 3,000 | 3,000 | - |
Shares Outstanding (Diluted) | 4,000 | 4,000 | 3,970 | 3,000 | 3,000 | - |
Shares Change | -0.00% | 0.76% | 32.33% | - | - | - |
EPS (Basic) | -0.01 | 0.00 | 0.01 | 0.01 | 0.01 | - |
EPS (Diluted) | -0.01 | 0.00 | 0.01 | 0.01 | 0.01 | - |
EPS Growth | - | -24.42% | -25.39% | -15.92% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -22.61 | -28.17 | 5.79 | 15.72 | 23 |
Free Cash Flow Per Share | - | -0.01 | -0.01 | 0.00 | 0.01 | - |
Gross Margin | 1.27% | 10.38% | 15.16% | 77.48% | 83.13% | 85.66% |
Operating Margin | -30.63% | -5.09% | 7.61% | 74.94% | 70.63% | 60.84% |
Profit Margin | -16.11% | 7.02% | 7.24% | 7.97% | 10.71% | 12.55% |
Free Cash Flow Margin | - | -10.34% | -10.13% | 2.26% | 6.94% | 11.31% |
EBITDA | -63.18 | -8.5 | 22.68 | 193.03 | 161.55 | 124.96 |
EBITDA Margin | -29.93% | -3.89% | 8.15% | 75.41% | 71.32% | 61.45% |
D&A For EBITDA | 1.48 | 2.63 | 1.5 | 1.21 | 1.56 | 1.26 |
EBIT | -64.66 | -11.13 | 21.18 | 191.81 | 159.99 | 123.7 |
EBIT Margin | -30.63% | -5.09% | 7.61% | 74.94% | 70.63% | 60.84% |
Effective Tax Rate | - | 3.87% | 8.10% | 11.64% | 17.11% | 15.34% |